is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness
Following the results of STEPs 1 to 4, the FDA approved semaglutide therapy in patients with obesity
Schedule your consultation today and take the first step toward renewed confidence and vitality
40 In the LIVE trial, which evaluated the effects of liraglutide on LV function in stable chronic HF patients with and without diabetes, at the end of treatment patients from the liraglutide group were able to walk 28 65 m longer during the 6MWT, compared with 3 89 m for patients in the placebo group, with a mean difference of 24 m
Thats double what analysts predicted
While current clinical evidence is preliminary, emerging case reports and observational studies provide early support for these mechanisms